Insider Selling: OrthoPediatrics (NASDAQ:KIDS) CFO Sells $224,129.25 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) CFO Fred Hite sold 12,993 shares of the business’s stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $17.25, for a total transaction of $224,129.25. Following the sale, the chief financial officer directly owned 277,477 shares in the company, valued at approximately $4,786,478.25. This represents a 4.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

OrthoPediatrics Trading Down 0.7%

NASDAQ KIDS opened at $16.54 on Friday. OrthoPediatrics Corp. has a 12-month low of $15.28 and a 12-month high of $26.40. The company has a fifty day simple moving average of $17.63 and a two-hundred day simple moving average of $17.92. The company has a current ratio of 5.55, a quick ratio of 2.65 and a debt-to-equity ratio of 0.28. The stock has a market cap of $418.13 million, a P/E ratio of -9.79 and a beta of 1.07.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Thursday, February 26th. The company reported ($0.26) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.11. OrthoPediatrics had a negative net margin of 16.77% and a negative return on equity of 6.70%. The firm had revenue of $61.61 million for the quarter, compared to analyst estimates of $61.27 million. On average, analysts forecast that OrthoPediatrics Corp. will post -0.93 earnings per share for the current year.

Institutional Trading of OrthoPediatrics

A number of hedge funds have recently modified their holdings of KIDS. Russell Investments Group Ltd. grew its holdings in OrthoPediatrics by 433.1% during the third quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after acquiring an additional 1,139 shares during the period. Northwestern Mutual Wealth Management Co. raised its position in OrthoPediatrics by 5,226.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after acquiring an additional 2,561 shares in the last quarter. Caption Management LLC acquired a new position in OrthoPediatrics in the third quarter valued at approximately $54,000. BNP Paribas Financial Markets lifted its holdings in OrthoPediatrics by 60.2% in the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock valued at $61,000 after acquiring an additional 1,235 shares during the period. Finally, State of Wyoming boosted its position in OrthoPediatrics by 189.7% in the 4th quarter. State of Wyoming now owns 6,822 shares of the company’s stock worth $121,000 after purchasing an additional 4,467 shares in the last quarter. Hedge funds and other institutional investors own 69.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on KIDS shares. Weiss Ratings restated a “sell (e+)” rating on shares of OrthoPediatrics in a research note on Thursday, January 22nd. BTIG Research upped their target price on OrthoPediatrics from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Friday, February 27th. Canaccord Genuity Group started coverage on shares of OrthoPediatrics in a report on Wednesday, December 10th. They issued a “buy” rating and a $24.00 price target on the stock. Needham & Company LLC raised their price target on shares of OrthoPediatrics from $26.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, February 27th. Finally, Truist Financial lifted their price objective on shares of OrthoPediatrics from $19.00 to $20.00 and gave the company a “hold” rating in a research note on Monday, March 2nd. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $24.67.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.